Eficacia de la hialuronidasa retrobulbar en el tratamiento de la ceguera provocada por rellenos cosméticos. Revisión sistemática / Effectiveness of retrobulbar hyaluronidase in the treatment of visual loss caused by periocular hyaluronic acid injection. A systematic review

Introducción La pérdida visual relacionada con la inyección periocular de rellenos con fines cosméticos es infrecuente pero muy grave. Como recomendaciones protocolizadas ante la pérdida visual por inyección intravascular inadvertida de ácido hialurónico se encuentran, entre otras, la inyección de hialorunidasa en el espacio retroocular. Es de esperar que, dada la creciente demanda de tratamientos de rellenos estéticos y la gran heterogeneidad de profesionales que pueden administrarlos, el número de casos y complicaciones relacionadas con estos procedimientos se incremente de manera sustancial. Objetivo Evaluar si existe evidencia científica para recomendar la inyección retroocular de hialuronidasa en el tratamiento de pérdidas visuales relacionadas con la inyección periocular de ácido hialurónico cosmético. Material y métodos Hemos realizado una búsqueda de artículos publicados en inglés y español siguiendo la declaración PRISMA sobre el uso de hialuronidasa retrobulbar para revertir la pérdida de visión producida por los rellenos de ácido hialurónico. Los artículos revisados incluyeron los casos clínicos y las investigaciones experimentales. Identificamos a un total de 13 pacientes en esta revisión siguiendo unos criterios de inclusión y exclusión definidos. Finalmente, incluimos 15 artículos en el estudio, 13 de ellos fueron casos/series de casos. Los 2artículos restantes son estudios experimentales en animales con grupo control, en los que, tras provocar una oclusión selectiva de la arteria oftálmica, se administran inyecciones seriadas de hialuronidasa retroocular con control de la función visual. Resultados De los 15 artículos incluidos en el estudio, recogimos los datos de un total de 17 pacientes que, tras inyección de ácido hialurónico facial por motivos estéticos, presentaron una disminución brusca de la visión y en los que se inyectaron dosis variables de hialuronidasa retroocular (AU)

Introduction Blindness after periocular cosmetic filler injection is a rare but devastating complication. Complication management protocols recommend injecting retrobulbar hyaluronidase if visual loss related to accidental intravascular injection of hyaluronic acid occurs. Given the dramatic increase in cosmetic filler injections and the variety of professionals that can deliver them, it is reasonable to assume that the incidence of complications will rise significantly. Objective To evaluate if there is evidence-based efficacy of retrobulbar hyaluronidase injection in visual loss secondary to periocular cosmetic filler injection. Material and methods The authors performed a search of English and Spanish language articles following the PRISMA statement published on the use of retrobulbar hyaluronidase to reverse vision loss precipitated by hyaluronic acid gel fillers. Articles reviewed included case reports/series and experimental investigations. We identified a total of 13 patients in this review following defined inclusion and exclusion criteria. Finally, we included 15 articles in the study, 12 of them were cases / case series. The 2remaining articles are experimental studies in animals with a control group, in which after causing selective occlusion of the ophthalmic artery, serial injections of retroocular hyaluronidase are administered with control of visual function. Results Of the 15 articles included in the study, we studied 17 patients treated with retrobulbar hyaluronidase for hyaluronic acid-induced blindness. Improvement was demonstrated in 3 cases. Animal studies demonstrate variable data are provided regarding the recovery of visual acuity. Conclusions There is no confirmed evidence of retrobulbar hyaluronidase injection effectiveness in treating visual loss due to accidental intravascular injection of hyaluronic acid. More studies are needed to show the efficacy of hyaluronidase as a treatment for blindness caused by hyaluronic acid (AU)

Effectiveness of retrobulbar hyaluronidase in the treatment of visual loss caused by periocular hyaluronic acid injection. A systematic review.

INTRODUCTION: Blindness after periocular cosmetic filler injection is a rare but devastating complication. Complication management protocols recommend injecting retrobulbar hyaluronidase if visual loss related to accidental intravascular injection of hyaluronic acid occurs. Given the dramatic increase in cosmetic filler injections and the variety of professionals that can deliver them, it is reasonable to assume that the incidence of complications will rise significantly. OBJECTIVE: To evaluate if there is evidence-based efficacy of retrobulbar hyaluronidase injection in visual loss secondary to periocular cosmetic filler injection. MATERIAL AND METHODS: The authors performed a search of English and Spanish language articles following the PRISMA statement published on the use of retrobulbar hyaluronidase to reverse vision loss precipitated by hyaluronic acid gel fillers. Articles reviewed included case reports/series and experimental investigations. We identified a total of 13 patients in this review following defined inclusion and exclusion criteria. Finally, we included 15 articles in the study, 12 of them were cases / case series. The 2 remaining articles are experimental studies in animals with a control group, in which after causing selective occlusion of the ophthalmic artery, serial injections of retroocular hyaluronidase are administered with control of visual function. RESULTS: Of the 15 articles included in the study, we studied 17 patients treated with retrobulbar hyaluronidase for hyaluronic acid-induced blindness. Improvement was demonstrated in 3 cases. Animal studies demonstrate variable data are provided regarding the recovery of visual acuity. CONCLUSIONS: There is no confirmed evidence of retrobulbar hyaluronidase injection effectiveness in treating visual loss due to accidental intravascular injection of hyaluronic acid. More studies are needed to show the efficacy of hyaluronidase as a treatment for blindness caused by hyaluronic acid.

Hemorragia retrobulbar espontánea asociada a consumo de anticoagulantes / Spontaneous retrobulbar haemorrhage associated with anticoagulants

La hemorragia retrobulbar es un sangrado en la región intraorbitaria retroseptal que genera un síndrome compartimental orbitario. Se presenta el caso de una mujer de 86 años que acudió a Urgencias por dolor ocular y pérdida de visión en ojo izquierdo de seis horas de evolución. Presentaba tratamiento anticoagulante con 300 mg/día de Dabigatrán por fibrilación auricular como único antecedente médico. La exploración clínica fue compatible con hemorragia retrobulbar, diagnóstico confirmado por TAC urgente, realizándose de forma inmediata una cantotomía con cantolisis. Se realizó RMN orbitaria que descartó la existencia de malformaciones arteriovenosas como factor desencadenante, diagnosticándose de hemorragia retrobulbar espontánea asociada a consumo de anticoagulantes. La singularidad de este caso radica en formar parte del pequeño porcentaje de hemorragias retrobulbares que no se asocian a causa traumática ni postquirúrgica así como en ilustrar una localización muy poco frecuente de sangrado asociado a anticoagulación.(AU)

Retrobulbar hemorrhage consists of bleeding in the retroseptal intraorbital region generating an orbital compartment syndrome. We present the case of an 86-year-old woman who came to the Emergency Room due to ocular pain and loss of vision in the left eye of six hours of evolution. The only medical history was atrial fibrillation on anticoagulant treatment with Dabigatran 300mg daily. The clinical examination was compatible with retrobulbar hemorrhage and the urgent CT confirmed the diagnosis, performing immediately after a canthotomy with cantolysis. In the absence of triggering factors, an orbital MRI was performed which ruled out the existence of arteriovenous malformations, diagnosing spontaneous retrobulbar hemorrhage associated with the use of anticoagulants. The uniqueness of this case is that it forms part of the small percentage of retrobulbar hemorrhages that are not associated with trauma or postsurgical causes, as well as in illustrating a very rare location of bleeding associated with anticoagulation.(AU)

La cuestión está en el síndrome general (y la pérdida de visión) / The question is the general syndrome (and the vision loss)

We present the case of a man who refers weight loss, asthenia, andrectal bleeding. After the initial tests a rectal ulcer was found througha colonoscopy. After that, he consulted for acute loss of vision, withfindings in the ophthalmological explorations compatible with bilateralposterior uveitis. We propose the differential diagnosis of the rectalulcer in one hand and of the bilateral posterior uveitis in the other,with the aim of reaching a diagnosis which involves both alterations.

Presentamos el caso de un hombre que consulta por pérdida depeso, astenia y rectorragia. En los estudios iniciales se objetiva una úlcera rectal en la colonoscopia realizada. Posteriormente presenta pérdida de visión brusca, con hallazgos en la exploración oftalmológica compatibles con uveítis posterior bilateral.Se plantea el diagnóstico diferencial por un lado de la úlcera rectal ypor otro de la uveítis posterior bilateral para llegar a un diagnósticoque aúne ambas alteraciones.

Hipertensión intracraneal idiopática: principales aspectos neurofisiológicos, diagnósticos y terapéuticos / Idiopathic Intracranial Hypertension: Main Neurophysiological, Diagnosis and Therapeutic Features

La hipertensión intracraneal idiopática, también conocida como pseudotumor cerebral, es una enfermedad caracterizada por un incremento de la presión intracraneal no atribuible a masas cerebrales o a alteraciones estructurales focales, con composición normal del líquido cefalorraquídeo. En estudios imagenológicos pueden observarse ventrículos normales o pequeños. Se desconoce su etiología y patogenia. Es causa eludible de pérdida de la visión, tanto en adultos como en niños. El tratamiento es con frecuencia efectivo y la mayoría de los pacientes experimentan una resolución completa de los síntomas sin persistencia de déficits.(AU)

Idiopathic intracranial hypertension, also known as pseudotumor cerebri is a condition characterized by increased intracranial pressure, not caused to mass lesions or focal structural abnormalities, or with normal composition of the cerebrospinal fluid. Ventricles can be observed normal or small in imaging studies. Its etiology and pathogenesis are unknown. Idiopathic intracranial hypertension is an avoidable cause of visual loss, in both adults and children. Treatment is usually effective, and most patients have observed complete resolution of symptoms without persistent deficits.(AU)

An atypical presentation of visual conversion disorder.

Nonorganic vision loss accounts for up to 5% of patients and presents in two forms, malingering and visual conversion disorder (VCD). It is described a case of VCD in a new mother struggling both with her husband being deployed overseas and the recent death of her father. In addition, she had been evaluated for a concussion secondary to a motor vehicle accident three months prior. An inexpensive series of clinical tests were performed to rule out organic disease and obtained equivocal results. Some tests revealed intact vision in the affected eye while others supported a neurological cause for the vision loss. However, the patient quickly recovered normal visual acuity when encouraged to discuss situations that have been causing emotional stress. This almost immediate recovery of vision confirmed the diagnosis of VCD. This report should make primary eye care professionals more aware of visual conversion disorder and its clinical evaluation.

Visual loss after hip and shoulder arthroplasty, two case reports.

PURPOSE: The report of two cases of ischemic optic neuropathy after hip and shoulder arthroplasty under general anesthesia. One of them is the first reported posterior ischemic optic neuropathy after shoulder surgery up to our knowledge. METHODS: Case reports and review of the literature reporting also data of the anesthesia period. RESULTS: The first case is a 74-year-old male patient with postoperative visual loss after awakening from hip arthroplasty. He had bilateral visual loss due to an anterior ischemic optic neuropathy with no vascular risk factors associated, probably due to intraoperative blood loss and short periods of drop of his blood pressure. The second case is a 65-year-old man who developed postoperative visual loss because of posterior ischemic optic neuropathy in one single eye after shoulder arthroplasty. To the best of our knowledge there are only three cases reported of ischemic optic neuropathy after shoulder surgery and none of them due to posterior ischemia. This patient had history of vascular risk factors, such as hypertension and diabetes. The repeated tests during the follow up of the patients revealed no significant improvement of their visual function. CONCLUSIONS: Perioperative visual loss after hip and shoulder surgery is a very rare but fatal complication that is difficult to prevent with a poor visual prognosis. Both anesthetist and surgeon should be aware of this problem.

Acute eclipse retinopathy: a small case series.

We present four young patients with acute severe solar retinopathy after observation of the total eclipse on January 4, 2011 without appropriate eye protection. Funduscopic findings were accompanied by optical coherence tomography (OCT) investigation of the macula. All our patients were young (range 14-29 years). In three of the four patients we have been able to repeat OCT evaluation revealing that the retinal changes were reversible, but delineating mild pathology in the retinal pigment epithelium and photoreceptors. Best-corrected visual acuity in the fourth case was 6/24. In addition, macular edema, which has been previously described in literature, could not be demonstrated by OCT. In the two cases we performed an early fluorescein angiogram, no pathology was seen.